Clinical Trial Update: Ivermectin Versus Albendazole for Chronic Strongyloidiasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ivermectin to albendazole for chronic strongyloidiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Strongyloidiasis

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Mahidol University | Conditions: Chronic Strongyloidiasis | Phase 3 | Status: COMPLETED